Vol 7, No 2 (2017)
- Year: 2017
- Published: 26.06.2017
- Articles: 17
- URL: https://ogsh.abvpress.ru/jour/issue/view/22
Full Issue
REVIEWS
PERISTOMAL RECURRENCE OF LARYNGEAL CANCER (LITERATURE REVIEW)
Abstract
Treatment of recurrent laryngeal cancer remains challenging for clinicians. Peristomal reccurence is one of the severest complications of laryngeal cancer that occurs in 2–15 % of patients after laryngectomy and has a poor prognosis: the two-year survival rate is 45 % in patients with stage I and stage II recurrence (according to G.A. Sisson) and 9 % among patients with stage III and stage IV recurrence. Stomal recurrence usually occurs within 2 years after surgery. The following factors can influence that: location of the tumor in the subglottic region of the larynx, size of the primary tumor, presence of regional metastases, placement of a tracheostoma before laryngectomy, and submucosal spread of the tumor to the trachea. All these factors should be taken into account in patients» management, including prescription of adjuvant therapy and choosing a treatment strategy in patients with primary disease.
Since there are multiple factors that can influence peristomal reccurence development, the disease requires comprehensive evaluation in order to provide the most adequate treatment and to prevent stomal recurrence.
92-98
NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Abstract
Patients with head and neck squamous cell carcinoma diagnosed with recurrent tumor or distant metastases usually have the worst prognosis. Chemotherapeutic options are very limited in these patients; there is a probability of drug resistance development. The researchers continue to search more effective and less toxic drugs. In the current article, we analyze the results of the latest randomized clinical trials devoted the assessment of novel antitumor immunotherapeutic drugs – PD-1 inhibitors – in patients with head and neck squamous cell carcinoma. This studies reveal new possibilities for the treatment of these patients.
99-105
CLINICAL GUIDELINES
DIAGNOSIS AND TREATMENT OF MALIGNANT EPITHELIAL SKIN TUMORS (PROJECT)
Abstract
Objective and status of the guidelines. These Clinical guidelines consolidate opinions of the members of the expert task group on current problems of diagnosis and treatment of skin cancer at the modern stage of Russian clinical practice. The guidelines embody experience in diagnosis and treatment of this pathology of the leading specialists of scientific research institutes and large oncological centers of the Russian Federation. The guidelines were composed considering operation of oncological dispensaries with different bed capacities and diagnostic capabilities, and therefore opinions of some members of the group can differ from the version presented below. At the same time, the proposed for discussion guidelines make no claim to fully represent all aspects of the problem and can’t replace guidelines for doctors, textbooks, and scientific papers in this field.
The main objective of the guidelines is to improve early diagnosis of malignant skin pathology, its treatment, functional and social rehabilitation of patients with this pathology.
The Guidelines are based on analysis of the current state of diagnosis and treatment of malignant skin tumors of the head and neck considering experience of the leading specialists in the field and reports presented at the task group meeting on February 17th, 2017 in Kazan.
114-128
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
THE SIGNIFICANCE OF THE METHOD OF ULTRASONIC RESEARCH OF A THYROID GLAND WITH CONTRAST ENHANCEMENT IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR FORMATIONS
Abstract
Introduction. Currently thyroid nodules are a widespread problem in clinical oncology and head and neck cancer, malignant focal lesions constitute more than 15–20 %. Accurate diagnosis is very important and determines treatment, as well as the volume of surgical intervention.
Objective – determination of the diagnostic value of the method of contrast-enhanced ultrasound in the diagnosis of thyroid cancer. Reference materials were the results of the histological study of surgical specimens.
Method. Performed a retrospective analysis of medical records of 42 patients who underwent surgery at the surgical department of head and neck tumors on the verified thyroid cancer in the N.N. Petrov Research Institute of Oncology at the Ministry of Health of Russia. The number of female patients was 36 persons (85.5 %), the number of men was 6 people (14.5 %). The average age of patients among men was 55.5 years, women – 46 years. All patients underwent surgical treatment in the amount of extirpation of the thyroid gland – 16 patients (37.5 %), hemithyroidectomy – 26 patients (62.5 %).
Results. The sensitivity of ultrasound with contrast in the diagnosis of cancer of the thyroid gland was 94.11 %, specificity was 87.5 %, diagnostic accuracy – 92.8 %.
Conclusions. The technique of ultrasound nodules thyroid with intravenous contrast enhancement has an excellent diagnostic properties, allowing to identify and verify thyroid cancer is 8 % more accurately in comparison with standard ultrasound technique.
12-15





